|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 18.98 CNY | +0.74% |
|
+1.17% | +7.72% |
| 04-24 | Dashenlin Pharma's Q1 Profit Rises 11% | MT |
| 04-24 | Dashenlin Pharma's 2025 Profit Jumps 35%, Revenue Rises 4% | MT |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | 24.7 | +30.14% | 7 | ||||||
| 60.65 | +75.62% | 16 | ||||||
| 4.639 | +49.33% | 15 | ||||||
| 2,976 | +10.55% | 10 | ||||||
| 33.22 | +46.32% | 12 | ||||||
| 124.21 | +31.16% | 9 | ||||||
| 327.88 | +51.41% | 8 | ||||||
| - | - | 1,415 | +184.74% | 1 | ||||
| 47 | +14.66% | 6 | ||||||
| 84.2 | +21.5% | 10 | ||||||
| 37.19 | +22.93% | 8 | ||||||
| 14.86 | +28.23% | 5 | ||||||
| 54.32 | +33.21% | 8 | ||||||
| 1,013.14 | +40.52% | 7 | ||||||
| - | 92.5 | +24.58% | 2 | |||||
| - | 5,100 | +22.74% | 2 | |||||
| Average | 713.09 | +42.98% | 8 | ||||||
| Weighted average by Cap. | 548.7 | +52.13% | 11 |
Select your edition
All financial news and data tailored to specific country editions
